News Image

NASDAQ:LNTH is showing decent growth, but is still valued reasonably.

By Mill Chart

Last update: Nov 23, 2023

Our stock screener has singled out LANTHEUS HOLDINGS INC (NASDAQ:LNTH) as an attractive growth opportunity. NASDAQ:LNTH is demonstrating remarkable growth potential while maintaining strong financial indicators, making it a reasonably priced option. We'll explore this further.

What does the Growth looks like for NASDAQ:LNTH

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:LNTH has received a 8 out of 10:

  • The Earnings Per Share has grown by an impressive 88.71% over the past year.
  • The Earnings Per Share has been growing by 33.91% on average over the past years. This is a very strong growth
  • LNTH shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.43%.
  • The Revenue has been growing by 23.05% on average over the past years. This is a very strong growth!
  • Based on estimates for the next years, LNTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.93% on average per year.
  • The Revenue is expected to grow by 14.68% on average over the next years. This is quite good.

Evaluating Valuation: NASDAQ:LNTH

An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NASDAQ:LNTH has received a 8 out of 10:

  • A Price/Earnings ratio of 11.68 indicates a reasonable valuation of LNTH.
  • Based on the Price/Earnings ratio, LNTH is valued cheaply inside the industry as 97.52% of the companies are valued more expensively.
  • LNTH is valuated cheaply when we compare the Price/Earnings ratio to 24.54, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 11.00, which indicates a very decent valuation of LNTH.
  • LNTH's Price/Forward Earnings ratio is rather cheap when compared to the industry. LNTH is cheaper than 97.52% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of LNTH to the average of the S&P500 Index (19.58), we can say LNTH is valued slightly cheaper.
  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 80.69% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 94.55% of the companies listed in the same industry.
  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LNTH has a very decent profitability rating, which may justify a higher PE ratio.
  • LNTH's earnings are expected to grow with 14.90% in the coming years. This may justify a more expensive valuation.

Health Examination for NASDAQ:LNTH

ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. NASDAQ:LNTH was assigned a score of 7 for health:

  • An Altman-Z score of 5.24 indicates that LNTH is not in any danger for bankruptcy at the moment.
  • LNTH has a better Altman-Z score (5.24) than 80.69% of its industry peers.
  • LNTH has a debt to FCF ratio of 2.17. This is a good value and a sign of high solvency as LNTH would need 2.17 years to pay back of all of its debts.
  • LNTH has a Debt to FCF ratio of 2.17. This is amongst the best in the industry. LNTH outperforms 90.59% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for LNTH, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
  • A Current Ratio of 5.37 indicates that LNTH has no problem at all paying its short term obligations.
  • The Current ratio of LNTH (5.37) is better than 68.81% of its industry peers.
  • LNTH has a Quick Ratio of 5.05. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
  • LNTH has a better Quick ratio (5.05) than 72.28% of its industry peers.

A Closer Look at Profitability for NASDAQ:LNTH

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:LNTH has achieved a 7:

  • Looking at the Return On Assets, with a value of 6.84%, LNTH belongs to the top of the industry, outperforming 88.12% of the companies in the same industry.
  • The Return On Equity of LNTH (14.90%) is better than 92.08% of its industry peers.
  • LNTH's Return On Invested Capital of 11.01% is amongst the best of the industry. LNTH outperforms 93.56% of its industry peers.
  • The Profit Margin of LNTH (8.63%) is better than 84.16% of its industry peers.
  • LNTH's Operating Margin of 15.55% is amongst the best of the industry. LNTH outperforms 88.61% of its industry peers.
  • LNTH's Gross Margin of 63.31% is fine compared to the rest of the industry. LNTH outperforms 65.35% of its industry peers.
  • In the last couple of years the Gross Margin of LNTH has grown nicely.

More Affordable Growth stocks can be found in our Affordable Growth screener.

Check the latest full fundamental report of LNTH for a complete fundamental analysis.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (4/19/2024, 7:01:46 PM)

After market: 63.81 0 (0%)

63.81

+1.48 (+2.37%)

LNTH News

News Image2 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
News Image2 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference...

News Image3 days ago - ChartmillNASDAQ:LNTH: a strong growth stock preparing for the next leg up?.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating.

News Image8 days ago - The Motley Fool2 Magnificent Stocks You Probably Never Heard Of

You might not have heard of these stocks, but they're worth putting on your radar.

News Image9 days ago - ChartmillInvestors should take notice of NASDAQ:LNTH—it offers a great deal for the fundamentals it presents.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH), an undervalued stock with good fundamentals.

News Image9 days ago - InvestorPlaceWall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for April 2024

Explore three Russell 2000 stocks with strong buy ratings for April 2024, offering high growth potential and lower valuations.

News Image17 days ago - Market News VideoInteresting LNTH Put And Call Options For May 17th
News Image18 days ago - ChartmillNASDAQ:LNTH is showing good growth, while it is not too expensive.

Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH.

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

News Image2 months ago - Lantheus Holdings, Inc.Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

DEFINITY is the #1 utilized ultrasound enhancing agent in the U.S. for patients with suboptimal echocardiograms

LNTH Links
Follow us for more